Through his public-benefit corporation Star Syringe, Koska first needed to embark on a public policy and advocacy campaign to ...
Argenx banks on key prefilled syringe approval for Vyvgart to help drive profitability in 2025: exec
Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a ...
Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYV™ (denosumab ...
Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...
The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.
You can’t get pre-arrival services if you’re coming to Canada for a short time. For example, temporary residents visiting, studying or working in Canada on a visa or permit don’t qualify for ...
Pre-arrival organizations help you get information on how to move to, live and work in Canada. Pre-arrival service organizations assess your needs and create a personalized plan to help you settle in ...
The girl was found unresponsive in the bathtub at a Brooklyn home on Friday, Feb. 7, according to reports Escher Walcott is a Writer/Reporter at PEOPLE, covering stories in Entertainment, Style ...
Kesimpta is a brand-name subcutaneous injection prescribed for certain forms of multiple sclerosis (MS). Kesimpta begins working right away, but it may take some time for you to notice relief in ...
“Paradise,” now streaming on Hulu, begins as Xavier Collins (Sterling K. Brown) goes for a morning run in his picture-perfect, neat and tidy neighborhood. It’s reminiscent of the new ...
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK's Recombinant Zoster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results